For GLP-1 users, who often experience reduced appetite and caloric intake, every calorie counts
Long-Term Safety Concerns: While short-term data are promising, the long-term impact of GLP-1, dual, and triple agonists on adolescent metabolic health remains unclear
It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Mol Metab 2017;6:4406.ArticlePubMedPMC 60
5 Mounjaro (Tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, & 15 mg) subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes
This feeling drained state is a common cause of fatigue, so staying hydrated is key to preventing it.